Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis I: Introduction01:22

Pericarditis I: Introduction

32
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
32
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

47
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
47
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

44
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
44
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

69
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
69
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

77
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
77
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

84
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
84

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial.

Journal of the American Heart Association·2026
Same author

Constrictive Pericarditis and Bilateral Pleural Effusions Unmasked in an HLA-B27 Positive Patient.

JACC. Case reports·2026
Same author

Recurrent Pericarditis Evolving to Constrictive Pericarditis and Pericardiectomy Over 18 Years.

JACC. Case reports·2026
Same author

Managing Refractory Pericarditis in the Era of Biologic Therapy: A Cardio-Oncology-Based Risk Framework.

JACC. Advances·2026
Same author

Application of 2025 American Society of Echocardiography Guideline in Heart Failure With Preserved Ejection Fraction: Limitations of Left Atrial Volume Index and Left Atrial Reservoir Strain as Single Markers of Filling Pressure.

Journal of the American College of Cardiology·2026
Same author

Myxoid Pleomorphic Liposarcoma Imitating Recurrent Traumatic Hemopericardium.

JACC. Case reports·2026

Related Experiment Video

Updated: Oct 2, 2025

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.6K

Pericardial Involvement in Sarcoidosis.

Gauranga Mahalwar1, Ashwin Kumar1, Ankit Agrawal1

  • 1Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute.

The American Journal of Cardiology
|March 1, 2022
PubMed
Summary

Sarcoidosis-induced pericardial disease is rare. This review of 27 cases found dyspnea and pericardial effusion common, with corticosteroids as a frequent treatment for sarcoid pericarditis.

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.3K
Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

838

Related Experiment Videos

Last Updated: Oct 2, 2025

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.6K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.3K
Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

838

Area of Science:

  • Cardiology
  • Pulmonology
  • Rheumatology

Background:

  • Pericardial disease is a rare complication of sarcoidosis.
  • Limited observational data exists on sarcoid-induced pericarditis.

Purpose of the Study:

  • To systematically review and analyze reported cases of pericardial disease secondary to sarcoidosis.
  • To understand the diagnosis and management of sarcoid-induced pericarditis.

Main Methods:

  • Systematic review of literature up to December 16, 2020.
  • Included case reports and case series detailing pericardial involvement in sarcoidosis.
  • Identified 14 reports with 27 patients.

Main Results:

  • Dyspnea (82%) was the most common symptom; lungs were the primary sarcoidosis site (77%).
  • Pericardial effusion (89%) was most frequent, followed by constrictive pericarditis and cardiac tamponade (48%).
  • Corticosteroids (82%) were a primary treatment; pericardiocentesis (59%) was a common intervention.

Conclusions:

  • Prevalence and incidence of sarcoid-induced pericardial disease are unclear.
  • Clinical presentations vary, often with asymptomatic pericardial effusions.
  • Corticosteroids and combination therapies are first-line; refractory cases may benefit from NSAIDs, colchicine, or biologics.